Washington, D.C – The Medical Imaging & Technology Alliance (MITA) – the leading trade association representing manufacturers of medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound therapeutic devices – commended Congressional leaders and the President for taking action to prevent Medicare cuts affecting healthcare providers across the country. President Biden signed the Protecting Medicare and American Farmers from Sequester Cuts Act (S. 610) into law on December 10 to provide a one-year increase in the Medicare Physician Fee Schedule (PFS) of three percent and another six-month of sequestration reductions.

The delay was passed shortly after MITA joined with seven other leading imaging and radiology groups in a letter to Congressional leadership expressing their concern with Medicare’s planned cuts to specialty providers.

“Already our nation’s healthcare providers are navigating financial hardships brought on by the COVID-19 pandemic, and these cuts would have only exacerbated these problems for both patients and providers,” said Patrick Hope, Executive Director, MITA. “We’re grateful Washington acted to provide necessary relief by avoiding these cuts.”

In addition to MITA, the letter was signed by the American Society of Radiologic Technologists (ASRT), the Association for Quality Imaging (AQI), Radiology Business Management Association (RBMA), Rayus Radiology, Shields Health Care, the Society of Diagnostic Medical Sonography (SDMS) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

To read the coalition letter, click here.

###

MITA is the collective voice of manufacturers of medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound therapeutic devices. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging innovations. These products include: magnetic resonance imaging (MRI), medical X-Ray equipment, computed tomography (CT) scanners, ultrasound, nuclear imaging, radiopharmaceuticals, and imaging information systems. MITA Member company technologies are an important part of our nation’s healthcare infrastructure and are essential for the screening, diagnosis, staging, managing, and effectively treating patients with cancer, heart disease, neurological degeneration, and numerous other medical conditions.